Dr. Eghbalpour Curriculum Vitae
We are delighted to present the latest issue of Advanced Therapeutics, showcasing pioneering research and critical reviews that reflect the dynamic and evolving landscape of modern healthcare.
In this issue, we begin with an intriguing study exploring the antidepressant effects of an aqueous-alcoholic extract of Portulaca oleracea (purslane) in a mouse model of asthma-induced depression. Through Open Field and Forced Swimming Tests, the authors provide compelling evidence for the therapeutic potential of plant-based interventions in managing complex neuropsychiatric conditions.
Addressing one of the most urgent threats in contemporary medicine, another featured article examines the multidrug resistance and clinical challenges posed by Acinetobacter species. As antimicrobial resistance continues to undermine treatment efficacy, understanding these emerging pathogens is critical for guiding future therapeutic strategies.
The positive impact of artificial intelligence in the field of anesthesia and anesthesia technology is also highlighted. This insightful review discusses how AI innovations are revolutionizing perioperative care, enhancing precision, safety, and clinical decision-making.
Environmental health concerns are brought to the forefront with a comprehensive analysis of microplastic-induced neurotoxicity. This article delves into the underlying pathways and mechanisms, shedding light on the potential link between microplastic exposure and neurodegenerative diseases—an emerging area that demands urgent scientific and public health attention.
Finally, we present a thorough review of recent advancements in hysterectomy techniques for the treatment of women's cancers. By critically evaluating new surgical approaches and clinical outcomes, the authors emphasize the importance of innovation in improving both survival rates and the quality of life for patients.
We trust that the articles in this issue will inspire continued research, innovation, and collaboration among our readers, as we collectively advance toward a future of more effective and compassionate healthcare.
Sincerely,
Director-in-Charge
Advanced Therapeutics
